← Eichor
Study identifier: NCT07701837 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Placental Progesterone Membrane Receptors in Fetal Growth Restriction

Condition: Fetal Growth Restriction · Placenta · Progesterone Membrane Receptor  ·  Sponsor: Samsun University

PhaseN/A
Planned participants90
Who can joinFemale, 18 Years to 45 Years
Healthy volunteersYes

About this study

This prospective observational case-control study aims to compare placental expression levels of progesterone membrane receptors, including PGRMC1, PGRMC2, and PAQR family receptors, between pregnancies complicated by intrauterine growth restriction (IUGR) and uncomplicated healthy pregnancies. Placental tissue samples obtained at delivery will be analyzed using quantitative real-time polymerase chain reaction (qRT-PCR). The study also aims to investigate the association between receptor expression levels and perinatal outcomes in order to better understand the role of progesterone membrane receptors in the pathophysiology of IUGR.

This description comes directly from the study's public registry record.

Talk to the study team

Canan SOYER ÇALIŞKAN, MD, Associate Professor  ·  + 90 532 203 55 38  ·  canan.caliskan@samsun.edu.tr

Canan SOYER ÇALIŞKAN, MD, Associate Professor  ·  90 362 311 15 40  ·  canan.caliskan@samsun.edu.tr

Always discuss trial participation with your own doctor first.

Locations (1)

Samsun University Faculty of Medicine Samsun Training and Research HospitalSamsun, Turkey (Türkiye)Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07701837